https://simplywall.st/stocks/dk/pharmaceuticals-biotech/cph-bava/bavarian-nordic-shares/dividend
Bavarian Nordic (CPSE:BAVA) Dividend Yield, History and Growth - Simply Wall St
Company does not have a record of paying a dividend.
history and growthbavarian nordicdividend yield
https://www.newswire.ca/news-releases/janssen-announces-collaboration-with-bavarian-nordic-to-develop-vaccine-for-chronic-human-papillomavirus-hpv-infections-562968351.html
Janssen Announces Collaboration with Bavarian Nordic to Develop Vaccine for Chronic Human...
/CNW/ - Janssen Pharmaceuticals, Inc. (Janssen) announced today that the company has entered into a definitive collaboration and license agreement with...
bavarian nordic
https://theorg.com/org/bavarian-nordic/teams/laboratory-scientists
Bavarian Nordic - Laboratory Scientists | The Org
The Laboratory Scientists team at Bavarian Nordic plays a crucial role in the development and quality assurance of innovative cancer immunotherapies and...
bavarian nordiclaboratory scientists
https://www.terrapinn.com/conference/vaccine-trials/sponsor-bavarian-nordic-as.stm
Bavarian Nordic A/S, sponsor of | Vaccine Trials 2016
Bavarian Nordic A/S, sponsor of - The meeting place for vaccine professionals from industry, academia, non-profit organizations and government to discuss...
bavarian nordicsponsor ofvaccine trials2016
https://theorg.com/org/bavarian-nordic/teams/commercial-strategy-and-sales
Bavarian Nordic - Commercial Strategy and Sales | The Org
The Commercial Strategy and Sales team at Bavarian Nordic plays a crucial role in driving the company's market presence and revenue growth.
bavarian nordiccommercial strategysales
https://www.eib.org/de/projects/all/20160330
BAVARIAN NORDIC FILL & FINISH PRODUCTION SITE
This project will support Bavarian Nordic, a fully integrated Danish biotechnology company focused on the development, manufacturing and commercialisation of...
bavarian nordicfill finishproductionsite
https://www.finanznachrichten.de/chart-tool/aktie/bavarian-nordic-a-s.htm
BAVARIAN NORDIC Chartanalyse
Chart zur BAVARIAN NORDIC A/S Aktie. Alle Charts zu Ihren Aktien.
bavarian nordicchartanalyse
https://www.finanznachrichten.de/nachrichten-2025-04/65072867-resolutions-of-the-annual-general-meeting-2025-of-bavarian-nordic-a-s-399.htm
Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S
COPENHAGEN, Denmark, April 9, 2025 - Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results: The Annual Report for...
annual general meeting 2025of thebavarian nordicresolutions
https://theorg.com/org/bavarian-nordic/teams/it-and-technical-support
Bavarian Nordic - IT and Technical Support | The Org
The IT and Technical Support team at Bavarian Nordic plays a crucial role in ensuring the seamless operation of technological infrastructure that underpins the...
it and technical supportbavarian nordic
https://www.eib.org/en/press/all/2018-216-investeu-european-support-for-bavarian-nordics-vaccine-production
Denmark: #InvestEU - European support for Bavarian Nordic's vaccine production
The European Union is supporting biotech company Bavarian Nordic with a EUR 30m loan from the EIB. The loan is guaranteed under the European Fund for Strategic...
support forbavarian nordicdenmarkinvesteueuropean
https://www.epo.org/de/boards-of-appeal/decisions/t111089eu1
T 1089/11 (Serum-free medium/BAVARIAN NORDIC) vom 12.12.2017
serum freebavarian nordic108911
https://www.republicworld.com/health/who-approves-bavarian-nordic-s-mpox-vaccine-for-adolescents
WHO Approves Bavarian Nordic's Mpox Vaccine For Adolescents | Republic World
Oct 14, 2024 - The Jynneos vaccine received prequalification for adolescents on October 8, according to a World Health Organisation (WHO) statement.
bavarian nordicmpox vaccinefor adolescentsapproves
https://www.marketscreener.com/news/bavarian-nordic-receives-swiss-approval-for-chikungunya-vaccine-ce7e50dddb81f32d
Bavarian Nordic Receives Swiss Approval for Chikungunya Vaccine | MarketScreener
Apr 16, 2026 - Vaccine maker Bavarian Nordic said Thursday it received approval for its chikungunya vaccine from the Swiss Agency for Therapeutic Products, or Swissmedic. The...
bavarian nordicchikungunya vaccinereceivesswissapproval
https://www.eib.org/en/projects/all/20140665
BAVARIAN NORDIC INFECTIOUS DISEASE & CANCER RDI
The project covers the promoter's research activities in developing novel vaccines against infectious diseases and oncology benefiting from the proprietary...
bavarian nordicinfectious diseasecancer
https://www.macrotrends.net/stocks/charts/BVNRY/bavarian-nordic/financial-statements
Bavarian Nordic Financial Statements 2015-2026 | BVNRY | MacroTrends
Ten years of annual and quarterly financial statements and annual report data for Bavarian Nordic (BVNRY). Income statements, balance sheets, cash flow...
bavarian nordicfinancial statements20152026macrotrends
https://www.marketscreener.com/news/bavarian-nordic-proposes-several-new-board-members-including-lundbeck-ceo-ce7e5eddd088f12c
Bavarian Nordic proposes several new board members, including Lundbeck CEO | MarketScreener
Mar 24, 2026 - Danish biotech firm Bavarian Nordic has proposed the re-election of four board members and the appointment of three new directors ahead of its annual general...
new board membersbavarian nordicproposesseveral
https://www.zawya.com/company/4295866173/bavarian-nordic
Bavarian Nordic A/S- Company Details on ZAWYA
See company data and latest news on ZAWYA. Access business development tools by signing up for the LSEG's Company Data product.
bavarian nordiccompany detailszawya
https://www.out.com/bavarian-nordic
Bavarian Nordic | Out.com
Stay informed on public health and vaccine advocacy. Explore Out's partnership with Bavarian Nordic focused on LGBTQ+ health and wellness.
bavarian nordic
https://www.republicworld.com/amp/health/who-approves-bavarian-nordic-s-mpox-vaccine-for-adolescents
WHO Approves Bavarian Nordic's Mpox Vaccine For Adolescents | Republic World
Oct 14, 2024 - The Jynneos vaccine received prequalification for adolescents on October 8, according to a World Health Organisation (WHO) statement.
bavarian nordicmpox vaccinefor adolescentsapproves
https://www.biospace.com/bavarian-nordic-announces-updated-overall-survival-data-from-combination-immunotherapy-data-of-prostvac-plus-ipilimumab-at-the-2015-b-genitourinary-c
Bavarian Nordic Announces Updated Overall Survival Data From Combination Immunotherapy Data Of...
bavarian nordicoverall survivalannouncesupdated
https://www.sofi.com/invest/stock/BVNKF/
Buy BAVARIAN NORDIC A S by Bavarian Nordic A/S Stock - BVNKF Stock Price, Quote & News | SoFi
See real time price charts for BVNKF stock, historical data, and recent news. Buy BVNKF stock online with no commission fees.
bavarian nordicby stock
https://www.asiaone.com/world/who-clears-bavarian-nordics-vaccine-mpox-sets-access-scheme
WHO clears Bavarian Nordic's vaccine for mpox, sets up access scheme, World News - AsiaOne
Sep 14, 2024 - The World Health Organisation and partners on Friday (Sept 13) set up a scheme to help bring mpox vaccines, tests and treatments to the most vulnerable people...
https://www.biospace.com/press-releases/capital-increase-in-bavarian-nordic-a-s-as-a-result-of-employee-warrant-exercise
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise - BioSpace
https://www.zawya.com/en/markets/equities/shares-soar-in-mpox-vaccine-maker-bavarian-nordic-j76ufv84
Shares soar in mpox vaccine maker Bavarian Nordic
Bavarian Nordic, whose vaccine has been licensed for preventing mpox since 2019, saw its shares rise more than eight percent on the Copenhagen Stock Exchange
mpox vaccinesharessoarmakerbavarian
https://ticotimes.net/2022/06/23/monkeypox-vaccine-maker-bavarian-nordic-ready-to-meet-demand
Monkeypox vaccine maker Bavarian Nordic ready to meet demand : The Tico Times | Costa Rica News |...
Jun 23, 2022 - The latest headlines and information from Costa Rica including monkeypox and the vaccine that will available for it.
https://www.einpresswire.com/article/447318169/bavarian-nordic-announces-acceptance-of-abstracts-and-oral-presentation-at-the-american-society-of-clinical-oncology-asco-annual-meeting
Bavarian Nordic Announces Acceptance of Abstracts and Oral Presentation at the American Society of...
May 16, 2018 - COPENHAGEN, Denmark, May 16, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced the acceptance of 4 poster presentations and one podium
https://simplywall.st/stocks/dk/pharmaceuticals-biotech/cph-bava/bavarian-nordic-shares/news/heres-why-shareholders-may-want-to-be-cautious-with-increasi-258
Here's Why Shareholders May Want To Be Cautious With Increasing Bavarian Nordic A/S' (CPH:BAVA) CEO...
Key Insights Bavarian Nordic's Annual General Meeting to take place on 9th of April Total pay for CEO Paul Chaplin...
https://www.finanznachrichten.de/nachrichten-2026-03/68055499-bavarian-nordic-a-s-bavarian-nordic-submits-data-to-ema-to-extend-mpox-and-smallpox-vaccine-approval-to-children-aged-2-11-years-399.htm
Bavarian Nordic A/S: Bavarian Nordic Submits Data to EMA to Extend Mpox and Smallpox Vaccine...
Submission based on topline data from clinical study, demonstrating a comparable safety profile and a non-inferior immune response for MVA-BN in children aged...
https://www.mdpi.com/2076-393X/13/6/594
Target Trial Emulation of the Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Pre-Exposure...
Background: The MVA-BN vaccine is considered effective for preventing mpox in key populations, based on observational studies, though no randomized trials have...
https://www.biospace.com/bavarian-nordic-announces-fda-acceptance-and-priority-review-of-the-bla-for-its-chikungunya-vaccine
Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine...
https://www.epo.org/de/boards-of-appeal/decisions/t091149eu1
T 1149/09 (Vaccinia virus formulation/BAVARIAN NORDIC) vom 24.10.2013
vaccinia virus